Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
Transgeen in agreement with AstraZeneca to co-developfive armed oncolytic vaccinia virus candidates. Innovative oncolyticviruses resulting from this collaboration will use Transgene’sproprietary next generation viral platform Invir.IO
Industry leaders partner to help life sciences companies compliantlymanage global events
Clinical trial agreements are one of the most important agreements inthe pharma industry as no research can start without the right agreementin place between sponsor and host organisation.
Mission Therapeutics today announced the appointment of Dr. James Summers asan independent member to its Board of Directors, with immediate effect.
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV LONDON–(BUSINESS WIRE)–ViiV…
Seed will enable growth of the PolyProx team and furtherdevelop our technology over the next two years
Allotex has treated over 50 eyes in the first phase of its clinical trials.